ASX - By Stock
|
CYC |
Revenue update ?
|
|
Lefevre
|
3 |
1.7K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3
|
1.7K
|
3
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.1K |
1.4M |
5 |
31/07/24 |
31/07/24 |
IPOs
|
2.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
CC9 |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
Lefevre
|
1 |
2.0K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
1
|
2.0K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
12 |
4.0K |
22 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
12
|
4.0K
|
22
|
|
ASX - By Stock
|
ENL |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
7 |
1.8K |
1 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
7
|
1.8K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.7K |
0 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
23
|
7.7K
|
0
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
10 |
3.4K |
5 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
10
|
3.4K
|
5
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
10 |
3.4K |
4 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
10
|
3.4K
|
4
|
|
IPOs
|
|
Re:
Nico.lab Pre IPO
|
|
Lefevre
|
710 |
576K |
0 |
29/07/24 |
29/07/24 |
IPOs
|
710
|
576K
|
0
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Lefevre
|
19 |
6.6K |
2 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
19
|
6.6K
|
2
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.1K |
1.4M |
5 |
25/07/24 |
25/07/24 |
IPOs
|
2.1K
|
1.4M
|
5
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL Receives Firm Commitments to Raise $10.5 Million
|
|
Lefevre
|
73 |
20K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
73
|
20K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Trading Halt
|
|
Lefevre
|
33 |
10K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
33
|
10K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL Receives Firm Commitments to Raise $10.5 Million
|
|
Lefevre
|
73 |
20K |
1 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
73
|
20K
|
1
|
|
ASX - By Stock
|
LTP |
Re:
In search of growth: Pharma deals target precommercial biotech assets
|
|
Lefevre
|
21 |
6.1K |
7 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
21
|
6.1K
|
7
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
6 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
67
|
14K
|
6
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.7K |
1 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
23
|
7.7K
|
1
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.7K |
0 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
23
|
7.7K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Updated Investor Presentation
|
|
Lefevre
|
3 |
1.3K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
14 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
14K
|
14
|
|
ASX - By Stock
|
BDX |
Re:
Ann: BCAL to Present at Bioshares Biotech Summit - Presentation
|
|
Lefevre
|
67 |
14K |
7 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
67
|
14K
|
7
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
Lefevre
|
185 |
68K |
4 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
185
|
68K
|
4
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Sales Update for Q4 FY2024
|
|
Lefevre
|
23 |
7.7K |
2 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
23
|
7.7K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Notice of initial substantial holder from IFL
|
|
Lefevre
|
10 |
4.0K |
12 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
10
|
4.0K
|
12
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
Lefevre
|
40 |
8.8K |
3 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
40
|
8.8K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
279 |
80K |
18 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
279
|
80K
|
18
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
279 |
80K |
9 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
279
|
80K
|
9
|
|
ASX - By Stock
|
LTP |
Re:
IT WORKS!
|
|
Lefevre
|
23 |
11K |
2 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
23
|
11K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
Lefevre
|
40 |
8.8K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
40
|
8.8K
|
0
|
|
ASX - By Stock
|
MAP |
Re:
Ann: Completion of Autoimmune Program with Ginkgo Bioworks
|
|
Lefevre
|
11 |
4.0K |
1 |
30/06/24 |
30/06/24 |
ASX - By Stock
|
11
|
4.0K
|
1
|
|
ASX - By Stock
|
MAP |
Re:
Ann: Completion of Autoimmune Program with Ginkgo Bioworks
|
|
Lefevre
|
11 |
4.0K |
1 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
11
|
4.0K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.5K |
13 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
19
|
9.5K
|
13
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm completes oversubscribed Share Purchase Plan
|
|
Lefevre
|
9 |
4.7K |
1 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
9
|
4.7K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.5K |
1 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
19
|
9.5K
|
1
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Change in substantial holding
|
|
Lefevre
|
16 |
5.0K |
6 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
16
|
5.0K
|
6
|
|
IPOs
|
Lithium |
Re:
Phoenix Water - PXW - Lithium - 100x
|
|
Lefevre
|
2.1K |
1.4M |
10 |
18/06/24 |
18/06/24 |
IPOs
|
2.1K
|
1.4M
|
10
|
|
ASX - By Stock
|
AGN |
Re:
$100M Market Cap
|
|
Lefevre
|
19 |
9.5K |
15 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
19
|
9.5K
|
15
|
|
ASX - By Stock
|
BDX |
Re:
Ann: Change of Director's Interest Notice
|
|
Lefevre
|
18 |
3.4K |
4 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
18
|
3.4K
|
4
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
Lefevre
|
60 |
28K |
17 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
60
|
28K
|
17
|
|
ASX - By Stock
|
CLG |
Re:
Ann: Business Update
|
|
Lefevre
|
60 |
28K |
7 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
60
|
28K
|
7
|
|
ASX - By Stock
|
ORA |
Re:
Ann: ORA - Investor Day Presentation 17 - 18 April 2024
|
|
Lefevre
|
38 |
24K |
3 |
16/06/24 |
16/06/24 |
ASX - By Stock
|
38
|
24K
|
3
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
Lefevre
|
185 |
68K |
5 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
185
|
68K
|
5
|
|
ASX - By Stock
|
CLG |
Re:
Consensus 2 strong buy
|
|
Lefevre
|
35 |
20K |
5 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
35
|
20K
|
5
|
|
ASX - By Stock
|
LTP |
Re:
Ann: SPONTAN achieves positive clinical study results
|
|
Lefevre
|
185 |
68K |
14 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
185
|
68K
|
14
|
|
ASX - By Stock
|
CC9 |
Re:
Wheres The Bottom
|
|
Lefevre
|
14 |
12K |
2 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
14
|
12K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: DSMB Confirms Safety of First Patients Dosed
|
|
Lefevre
|
28 |
15K |
15 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
28
|
15K
|
15
|
|
ASX - By Stock
|
AGN |
Re:
AGN Media thread
|
|
Lefevre
|
279 |
80K |
16 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
279
|
80K
|
16
|
|
ASX - By Stock
|
LTP |
Re:
Ann: Suspension from Quotation
|
|
Lefevre
|
30 |
10K |
11 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
30
|
10K
|
11
|
|
ASX - By Stock
|
AM7 |
Re:
Ann: Capital Raising
|
|
Lefevre
|
2 |
2.5K |
0 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
2
|
2.5K
|
0
|
|
IPOs
|
|
Re:
GYG - Guzman y gomez
|
|
Lefevre
|
9 |
7.1K |
3 |
01/06/24 |
01/06/24 |
IPOs
|
9
|
7.1K
|
3
|
|